Get the latest market trends in your inbox
Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul
Tampa-St. Petersburg news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg
Tourists with face masks walk through Union Square in New York City on Feb. 28. Photo: Timothy A. Clary/AFP via Getty Images
Some of the largest drugmakers — including AstraZeneca, Merck and Pfizer — have said that the coronavirus outbreak could affect their supplies or sales, the Wall Street Journal reports.
Between the lines: Drug shortages can end up being incredibly serious for patients, but they're not good for business either.
Details: The drug companies are trying to get ahead of the problem by looking for alternative sources of drug ingredients and supplies.
- Only one drug has gone into shortage so far because of the coronavirus, but the FDA hasn't said which drug or who makes it.
Go deeper: Coronavirus threatens shortages of about 150 drugs